Tri-MED Integrative Psychiatry & Sleep Medicine - Frisco
3140 Legacy Drive, Suite 710, Building 700, Frisco
4.7(762 Google reviews)
United States
4 listed treatment centers serving Frisco and the surrounding area.
3140 Legacy Drive, Suite 710, Building 700, Frisco
4.7(762 Google reviews)
11500 State Highway 121, Suite 930, Frisco
4.3(415 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Frisco.
5 miles away · Plano
5.5 miles away · McKinney
1400 North Coit Road, Suite 1103, McKinney
4.7(14 Google reviews)
5.6 miles away · McKinney
5.6 miles away · McKinney
6.5 miles away · McKinney
7300 Eldorado Parkway, Suite 270, McKinney
4.4(96 Google reviews)
6.9 miles away · The Colony
4901 Windhaven Parkway, Suite 200, The Colony
4.9(27 Google reviews)
For people in Frisco considering SPRAVATO®, the cost depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the supervised treatment and monitoring visit may generate charges. Ask for a written estimate covering both, rather than a medication-only quote.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials before deciding whether treatment meets its coverage rules. Ask the center which records it needs, who will submit the request, and how you will learn the decision. An authorization is not a guarantee that every charge will be paid.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. The four Frisco listings in this directory are marked as not accepting Medicare or Medicaid; confirm directly before scheduling. That listing information does not establish whether your benefits could cover treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, not people using government insurance. Eligibility restrictions apply, and assistance may not cover every visit-related charge. Ask for current program terms rather than assuming you qualify.
Before starting, ask the center and insurer:
Include transportation and time away from work in your planning.
SPRAVATO® treatment takes place only in a REMS-certified healthcare setting. You give yourself the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. This directory lists four Frisco centers offering Spravato, but their REMS certification status is not recorded here. Confirm certification with the center before arranging care.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly treatment during weeks 1–4, followed by weekly treatment during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume visits will become less frequent on a fixed timetable.
Monitoring lasts at least two hours after each dose, so the complete appointment may take longer once preparation and assessment are included. Ask about arrival requirements and the usual appointment window before requesting time off work. Early treatment can mean coordinating two appointments each week, plus travel and recovery time.
Arrange for someone else to take you home after every treatment. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its pickup requirements before relying on a taxi or rideshare, and have a backup plan if your driver cancels. Consider work duties, childcare, and other responsibilities when choosing appointment days.
If no Frisco center is listed when you search, or local appointments are unavailable, this directory also lists centers in McKinney, Dallas, and Fort Worth. Contact potential centers to confirm certification, availability, insurance arrangements, and whether repeated trips are practical for you.
This directory lists four Frisco centers offering SPRAVATO®, but their REMS certification status is not recorded. Ask each center to confirm that the treatment location is REMS-certified before booking. Also ask whether it is accepting new patients and how evaluations are arranged. If local options do not work for you, the directory also includes listings in McKinney, Dallas, and Fort Worth.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your history, previous treatments, and safety considerations to determine whether it is appropriate.
Coverage depends on your plan, treatment setting, and any authorization requirements. Insurers commonly request documentation of previous antidepressant trials. Ask about coverage for both the medication and the monitored visit. The four Frisco listings are marked as not accepting Medicare or Medicaid, so confirm directly. Medicare or Texas Medicaid may cover treatment in other arrangements, depending on the plan and setting; coverage is not guaranteed.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and increased blood pressure. Allow additional time for preparation and assessment. Someone else must take you home, and you cannot drive or operate machinery until the next day after a restful sleep.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history and medications with the clinician, and ask how the center monitors these risks and responds if problems occur.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. For an immediate emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.